N-(2-Methylbenzo[d]oxazol-6-yl)-2-(piperidin-1-yl)-5-(piperidin-1-ylsulfonyl)benzamide

Catalog No. :
ACTSAB877
CAS No. :
1030239-43-0
Molecular Formula :
C25H30N4O4S
Molecular Weight :
482.61

IUPAC Name:N-(2-methylbenzo[d]oxazol-6-yl)-2-(piperidin-1-yl)-5-(piperidin-1-ylsulfonyl)benzamide

N-(2-Methylbenzo[d]oxazol-6-yl)-2-(piperidin-1-yl)-5-(piperidin-1-ylsulfonyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Methylbenzo[d]oxazol-6-yl)-2-(piperidin-1-yl)-5-(piperidin-1-ylsulfonyl)benzamide
IUPAC NameN-(2-methylbenzo[d]oxazol-6-yl)-2-(piperidin-1-yl)-5-(piperidin-1-ylsulfonyl)benzamide
Molecular FormulaC25H30N4O4S
Molecular Weight482.61
SMILESO=C(NC1=CC=C2N=C(C)OC2=C1)C3=CC(S(=O)(N4CCCCC4)=O)=CC=C3N5CCCCC5
InChI KeyGRKDLYFAZRLESC-UHFFFAOYSA-N
SynonymBenzamide, N-(2-methyl-6-benzoxazolyl)-2-(1-piperidinyl)-5-(1-piperidinylsulfonyl)-
CAS No.1030239-43-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTSAB877 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZQNV843 route compound structure diagram
    ACZQNV8435676-60-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTSAB877 route product structure diagram
    ACTSAB8771030239-43-0
Inquiry

2. ACTSAB877 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTSAB877 route product structure diagram
    ACTSAB8771030239-43-0
Inquiry

Comments (0)